Medscape12m
Platelet-Rich Plasma Considered Effective but Not Approved for Hair Loss
The substantial data supporting platelet-rich plasma (PRP) therapy and exosomes for androgenic alopecia have yet to convince ...
Columbia Missourian1h
FDA approves first new schizophrenia drug in more than 30 years
The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.
Should You Buy Vertex Pharmaceuticals Stock Hand Over Fist Before Jan. 30?
Vertex Pharmaceuticals ( VRTX 3.06%) might be one of those special cases. Should you buy Vertex stock hand over fist before ...
labiotech2h
Ten first-in-class drugs on track for FDA approval in 2025
As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...
Jefferson Public Radio4h
Newsom committed California to making its own insulin. It’s at least a year behind his schedule
Gov. Gavin Newsom in 2020 signed a law allowing California to manufacture its own insulin, an effort to bring down the cost ...
Cowboy State Daily5h
Montana Fitness Guru Faces Jail For Selling Unapproved Drugs To Fight Man Boobs
A Montana fitness-based business owner faces jail time for illegally selling bodybuilding drugs that fight "man boobs." He ...
No, you don’t need the ‘Barbie drug’ to tan, whatever TikTok says. Here’s why melanotan-II is so risky
From nausea and vomiting to brain swelling and erection problems. These are just some of the side effects of melanotan-II.
Incyte And Syndax : FDA Approves Niktimvo 9 Mg And 22 Mg Vial Sizes
Incyte (INCY) and Syndax Pharmaceuticals (SNDX) announced that the U.S. Food and Drug Administration has approved Niktimvo ...
Incyte's and Syndax's Graft Disease Treatment Niktimvo Gets FDA Approval for Vial Sizes
Incyte and Syndax Pharmaceutical said the Food and Drug Administration approved their graft disease treatment Niktimvo antibody in nine milligram and 22 milligram vial sizes.
Becker's Hospital Review13h
Watchdog flags flaws in FDA's fast-track drug approvals
The OIG report points to gaps in documentation and decision-making transparency, particularly in the case of Aduhelm, where FDA records indicated only 13 meetings with Biogen, but congressional ...
Cure Today14h
The Subcutaneous Approval of Opdivo Makes Waves in Future of Cancer Care
Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...